18686-82-3 | 2-Mercapto-1,3,4-thiadiazole

Packsize	Purity	Availability	Price	Discounted Price
5g	98%	in stock	$21.00	$15.00
25g	98%(HPLC)	in stock	$33.00	$23.00
100g	98%(HPLC)	in stock	$68.00	$48.00
500g	98%	in stock	$103.00	$72.00

Description

• Catalog Number: AB62447
• Chemical Name: 2-Mercapto-1,3,4-thiadiazole
• CAS Number: 18686-82-3
• Molecular Formula: C2H2N2S2
• Molecular Weight: 118.1807
• MDL Number: MFCD00040404
• SMILES: Sc1nncs1
• NSC Number: 184817

Computed Properties

• Complexity: 97.7
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 6
• Hydrogen Bond Acceptor Count: 3
• Hydrogen Bond Donor Count: 1
• XLogP3: 0.9

Literature

• N-heterocyclic dicarboxylic acids: broad-spectrum inhibitors of metallo-β-lactamases with co-antibacterial effect against antibiotic-resistant bacteria.

  Bioorganic & medicinal chemistry letters 20120815

• 5-Eth-oxy-1,3,4-thia-diazole-2(3H)-thione.

  Acta crystallographica. Section E, Structure reports online 20120201

• Novel biotransformation process of podophyllotoxin to 4 β-sulfur-substituted podophyllum derivates with anti-tumor activity by Penicillium purpurogenum Y.J. Tang.

  Current medicinal chemistry 20120101

• N-(5-Sulfanyl-idene-4,5-dihydro-1,3,4-thia-diazol-2-yl)acetamide dimethyl sulfoxide disolvate.

  Acta crystallographica. Section E, Structure reports online 20120101

• Solid phase extraction of trace amounts of Ag, Cd, Cu, and Zn in environmental samples using magnetic nanoparticles coated by 3-(trimethoxysilyl)-1-propantiol and modified with 2-amino-5-mercapto-1,3,4-thiadiazole and their determination by ICP-OES.

  Journal of hazardous materials 20110615

• A facile synthesis and anticancer activity evaluation of spiro[thiazolidinone-isatin] conjugates.

  Scientia pharmaceutica 20110101

• 2,2'-Bi-1,3,4-thia-diazole-5,5'-diamine tetra-hydrate.

  Acta crystallographica. Section E, Structure reports online 20100901

• Bis(1,3,4-thia-diazol-2-yl) disulfide.

  Acta crystallographica. Section E, Structure reports online 20091001

• Quantitative structure-activity relationship (QSAR) studies on a series of 1,3,4-thiadiazole-2-thione derivatives as tumor-associated carbonic anhydrase IX inhibitors.

  Journal of enzyme inhibition and medicinal chemistry 20090601

• [5-(4-Bromo-phenoxy-meth-yl)-1,3,4-thia-diazole-2-thiol-ato]triphenyl-tin(IV).

  Acta crystallographica. Section E, Structure reports online 20090501

• Design, synthesis, and docking studies of new 1,3,4-thiadiazole-2-thione derivatives with carbonic anhydrase inhibitory activity.

  Bioorganic & medicinal chemistry 20071115